Page 168 - 2021_06-Haematologica-web

S. Fañanas-Baquero et al. recipients. Blood. 2010;115(18):3704-3707.
27. Oguro H, McDonald JG, Zhao Z, Umetani M, Shaul PW, Morrison SJ. 27- Hydroxycholesterol induces hematopoietic stem cell mobilization and extramedullary hematopoiesis during pregnancy. J Clin Invest. 2017;127(9):3392-3401.
28. Kim H-R, Lee J-H, Heo H-R, et al. Improved hematopoietic differentiation of human pluripotent stem cells via estrogen receptor signaling pathway. Cell Biosci. 2016;6(1):50.
29.Hayama T, Nawa Y, Ezaki T, Kotani M. Effects of estrogen on hepatic hemopoiesis in the adult mouse. Exp Hematol. 1983;11(7):611-617.
30. Perry MJ, Samuels A, Bird D, Tobias JH. Effects of high-dose estrogen on murine hematopoietic bone marrow precede those on osteogenesis. Am J Physiol Endocrinol Metab 2000;279(5):E1159-65.
31. Laird DJ, von Andrian UH, Wagers AJ. Stem cell trafficking in tissue development, growth, and disease. Cell. 2008;132(4):612-630.
32. Carroll KJ, Esain V, Garnaas MK, et al. Estrogen defines the dorsal-ventral limit of VEGF regulation to specify the location of the hemogenic endothelial niche. Dev Cell. 2014;29(4):437-453.
33. Di Vito C, Bergante S, Balduini A, et al. The oestrogen receptor GPER is expressed in human haematopoietic stem cells but not in mature megakaryocytes. Br J Haematol. 2010;149(1):150-152.
34. Coelingh Bennik, HJT; Bunschoten E. Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy. United States Patent. 2015; US 9034854B2.
35. Gérard C, Blacher S, Communal L, et al. Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland prolif- eration. J Endocrinol. 2015;224(1):85-95.
36. Jin J, Wang Y, Wang J, et al. Impaired hematopoiesis and delayed thrombopoietic recovery following sublethal irradiation in SRC3 knockout mice. Mol Med Rep. 2014;9(5):1629-1633.
37. Tajer P, Pike-Overzet K, Arias S, Havenga M, Staal FJT. Ex vivo expansion of hematopoiet- ic stem cells for therapeutic purposes: les- sons from development and the niche. Cells. 2019;8(2):169.
38. Girasole G, Jilka RL, Passeri G, et al. 17 beta- estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J
Clin Invest. 1992;89(3):883-891.
39. Kitajima Y, Doi H, Ono Y, et al. Estrogen
deficiency heterogeneously affects tissue specific stem cells in mice. Sci Rep. 2015;5:12861.
40.Kluft C, Zimmerman Y, Mawet M, et al. Reduced hemostatic effects with drospirenone-based oral contraceptives con- taining estetrol vs. ethinyl estradiol. Contraception. 2017;95(2):140-147.
41. Coelingh Bennink HJT, Verhoeven C, Zimmerman Y, Visser M, Foidart J-M, Gemzell-Danielsson K. Pharmacokinetics of the fetal estrogen estetrol in a multiple-ris- ing-dose study in postmenopausal women. Climacteric. 2017;20(3):285-289.
42. Coelingh Bennink HJT, Verhoeven C, Zimmerman Y, Visser M, Foidart J-M, Gemzell-Danielsson K. Pharmacodynamic effects of the fetal estrogen estetrol in post- menopausal women: results from a multi- ple-rising-dose study. Menopause. 2017;24 (6):677-685.
43. Singer CF, Bennink HJTC, Natter C, et al. Antiestrogenic effects of the fetal estrogen estetrol in women with estrogen-receptor positive early breast cancer. Carcinogenesis. 2014;35(11):2447-2451.
1670
haematologica | 2021; 106(6)